Jiasuer. Alifu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jiasuer. Alifu has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Fuad A. Abdu
School of Medical Sciences, Shandong Xiehe University, Jinan, China
2 shared publications - Lu Liu
Shanghai Tenth People’s Hospital, Tongji University School of Medicine
2 shared publications Wen Zhang
2 shared publications- Wenliang Che
Department of Cardiology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, China
2 shared publications Abdul-Quddus Mohammed
1 shared publication- Abdul-Quddus Mohammed
Department of Cardiology Shanghai Tenth People's Hospital, Tongji University School of Medicine Shanghai China
1 shared publication
Latest Publications
- Open Access
- 6 January 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (1) , e043169
Prognostic Impact of Infarct Size and Coronary Microvascular Function Via Cardiovascular Magnetic Resonance and Coronary Angiography‐Derived Index of Microcirculatory Resistance in Myocardial Infarction With Nonobstructive Coronary Arteries
Background: Infarct size (IS) and microvascular obstruction (MVO), measured by cardiovascular magnetic resonance, are key prognostic markers after myocardial infarction (MI). The index of microcirculatory resistance (IMR) predicts MVO and IS; however, its role in MI with nonobstructive coronary arteries (MINOCA) is unclear. This study explored the relationship between coronary angiography‐derived IMR, MVO, and IS in true MINOCA and assessed the prognostic value of coronary microvascular dysfunction (CMD), IS, and MVO. Methods: Patients with suspected MINOCA who completed cardiovascular magnetic resonance and coronary angiography‐derived IMR were included. CMD was defined as coronary angiography‐derived IMR >25, and IS as a percentage of left ventricular mass (IS%LV) measured by late gadolinium enhancement. True MINOCA was identified by cardiovascular magnetic resonance evidence of ischemia or infarction. Individuals with true MINOCA were divided into 3 groups: non‐CMD and IS%LV <16.78%, CMD or IS%LV ≥16.78%, and CMD with IS%LV ≥16.78%. Follow‐up for major adverse cardiovascular events was conducted. Results: Of 317 patients, 102 had true MINOCA (91.2% non–ST‐segment–elevation MI). CMD was similarly distributed across all suspected MINOCA. Coronary angiography‐derived IMR did not predict MVO or IS among true MINOCA. Over a median 27 months, 33.3% of patients with true MINOCA experienced major adverse cardiovascular events, with a higher risk in patients with CMD or IS%LV ≥16.78%. Multivariate Cox analysis revealed that CMD combined with IS%LV ≥16.78% had a hazard ratio (HR) of 7.40 (95% CI, 1.94–28.23), and either CMD or IS%LV ≥16.78% had an HR of 8.77 (95% CI, 2.57–29.94), but MVO did not. Sensitivity analyses excluding ST‐segment–elevation MI supported these findings. Conclusions: CMD with larger IS strongly predicts major adverse cardiovascular events in MINOCA, underscoring their utility in risk stratification, especially for non–ST‐segment–elevation MI. REGISTRATION: URL: https://clinicaltrials.gov . Unique identifier: NCT06502899.
- 6 January 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (1) , e043169
Open AccessPrognostic Impact of Infarct Size and Coronary Microvascular Function Via Cardiovascular Magnetic Resonance and Coronary Angiography‐Derived Index of Microcirculatory Resistance in Myocardial Infarction With Nonobstructive Coronary Arteries
Background: Infarct size (IS) and microvascular obstruction (MVO), measured by cardiovascular magnetic resonance, are key prognostic markers after myocardial infarction (MI). The index of microcirculatory resistance (IMR) predicts MVO and IS; however, its role in MI with nonobstructive coronary arteries (MINOCA) is unclear. This study explored the relationship between coronary angiography‐derived IMR, MVO, and IS in true MINOCA and assessed the prognostic value of coronary microvascular dysfunction (CMD), IS, and MVO. Methods: Patients with suspected MINOCA who completed cardiovascular magnetic resonance and coronary angiography‐derived IMR were included. CMD was defined as coronary angiography‐derived IMR >25, and IS as a percentage of left ventricular mass (IS%LV) measured by late gadolinium enhancement. True MINOCA was identified by cardiovascular magnetic resonance evidence of ischemia or infarction. Individuals with true MINOCA were divided into 3 groups: non‐CMD and IS%LV <16.78%, CMD or IS%LV ≥16.78%, and CMD with IS%LV ≥16.78%. Follow‐up for major adverse cardiovascular events was conducted. Results: Of 317 patients, 102 had true MINOCA (91.2% non–ST‐segment–elevation MI). CMD was similarly distributed across all suspected MINOCA. Coronary angiography‐derived IMR did not predict MVO or IS among true MINOCA. Over a median 27 months, 33.3% of patients with true MINOCA experienced major adverse cardiovascular events, with a higher risk in patients with CMD or IS%LV ≥16.78%. Multivariate Cox analysis revealed that CMD combined with IS%LV ≥16.78% had a hazard ratio (HR) of 7.40 (95% CI, 1.94–28.23), and either CMD or IS%LV ≥16.78% had an HR of 8.77 (95% CI, 2.57–29.94), but MVO did not. Sensitivity analyses excluding ST‐segment–elevation MI supported these findings. Conclusions: CMD with larger IS strongly predicts major adverse cardiovascular events in MINOCA, underscoring their utility in risk stratification, especially for non–ST‐segment–elevation MI. REGISTRATION: URL: https://clinicaltrials.gov . Unique identifier: NCT06502899.
- Open Access
- 1 January 2026
- Published by Wiley in Mediators of Inflammation
- Vol. 2026 (1) , e6052273
Associations of Inflammatory Prognosis Index With All‐Cause and Cardiovascular Mortality Among Individuals With Diabetes and Prediabetes: A Retrospective Cohort Study
Background: The systemic immune‐inflammatory index (SII) and the systemic inflammatory response index (SIRI) have shown prognostic value in diabetes mellitus (DM). However, the impact of the inflammatory prognosis index (IPI) remains unexamined. This retrospective cohort study investigates the predictive value of IPI, along with SIRI and SII, on all‐cause and cardiovascular disease (CVD) mortality in individuals with DM and prediabetes mellitus (pre‐DM). Method: We analyzed DM and pre‐DM individuals from the National Health and Nutrition Examination Survey (NHANES) (1999–2018), with follow‐up conducted until December 31, 2019. Cox models assessed the correlation of IPI, SIRI, and SII with mortalities, yielding hazard ratios (HRs) and 95% confidence intervals (CIs). We also utilized restricted cubic spline (RCS) analysis, Kaplan–Meier curves, and subgroup analyses. Results: The final analysis included 10,049 individuals with DM and pre‐DM. Over a mean follow‐up of 9 years, 2233 all‐cause mortalities occurred, with 612 attributed to CVD. Fully adjusted Cox regression analysis revealed a significant correlation between continuous and higher tertiles (T3) of IPI, SIRI, and SII and increased risk of all‐cause and CVD mortality across all models (all p < 0.05). Kaplan–Meier curves showed higher IPI, SIRI, and SII associated with elevated mortality risk (all log‐rank p < 0.001). RCS analysis demonstrated a nonlinear correlation between IPI and all‐cause and CVD mortality, as well as between SII and all‐cause mortality (nonlinear p < 0.001). However, SIRI exhibited a linear association with both all‐cause and CVD mortality. Conclusion: Elevated IPI, along with SIRI and SII, is linked to increased all‐cause and CVD‐related mortality in DM and pre‐DM, suggesting that incorporating IPI in routine screening could help identify high‐risk individuals for earlier interventions.
- 1 January 2026
- Published by Wiley in Mediators of Inflammation
- Vol. 2026 (1) , e6052273
Open AccessAssociations of Inflammatory Prognosis Index With All‐Cause and Cardiovascular Mortality Among Individuals With Diabetes and Prediabetes: A Retrospective Cohort Study
Background: The systemic immune‐inflammatory index (SII) and the systemic inflammatory response index (SIRI) have shown prognostic value in diabetes mellitus (DM). However, the impact of the inflammatory prognosis index (IPI) remains unexamined. This retrospective cohort study investigates the predictive value of IPI, along with SIRI and SII, on all‐cause and cardiovascular disease (CVD) mortality in individuals with DM and prediabetes mellitus (pre‐DM). Method: We analyzed DM and pre‐DM individuals from the National Health and Nutrition Examination Survey (NHANES) (1999–2018), with follow‐up conducted until December 31, 2019. Cox models assessed the correlation of IPI, SIRI, and SII with mortalities, yielding hazard ratios (HRs) and 95% confidence intervals (CIs). We also utilized restricted cubic spline (RCS) analysis, Kaplan–Meier curves, and subgroup analyses. Results: The final analysis included 10,049 individuals with DM and pre‐DM. Over a mean follow‐up of 9 years, 2233 all‐cause mortalities occurred, with 612 attributed to CVD. Fully adjusted Cox regression analysis revealed a significant correlation between continuous and higher tertiles (T3) of IPI, SIRI, and SII and increased risk of all‐cause and CVD mortality across all models (all p < 0.05). Kaplan–Meier curves showed higher IPI, SIRI, and SII associated with elevated mortality risk (all log‐rank p < 0.001). RCS analysis demonstrated a nonlinear correlation between IPI and all‐cause and CVD mortality, as well as between SII and all‐cause mortality (nonlinear p < 0.001). However, SIRI exhibited a linear association with both all‐cause and CVD mortality. Conclusion: Elevated IPI, along with SIRI and SII, is linked to increased all‐cause and CVD‐related mortality in DM and pre‐DM, suggesting that incorporating IPI in routine screening could help identify high‐risk individuals for earlier interventions.